Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
Nov 21, 2008 09:41 AM
- NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting
Nov 05, 2008 08:01 AM
- NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
Nov 03, 2008 07:12 AM
- NxStage Reports Third Quarter 2008 Financial Results
Nov 03, 2008 07:05 AM
- NxStage Reports Positive Interim Quality of Life Results from Landmark FREEDOM Study Comparing Clinical and Economic Benefits of its Daily Home Hemodialysis Therapy with Thrice-Weekly In-Center Treatment
Oct 24, 2008 10:32 AM
- NxStage Announces Streamline(TM) Blood Tubing Set Supply Agreement with Renal Advantage Inc.
Oct 21, 2008 09:24 AM
- NxStage to Report Third Quarter 2008 Financial Results
Oct 13, 2008 07:30 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: MDGC, EFJI, VRNM, PLUG, NXTM, RFMD
Oct 02, 2008 09:20 AM
- NxStage Medical to Present at JMP Securities Healthcare Focus Conference
Sep 30, 2008 04:12 PM
- NxStage Named Fastest Growing Company in Massachusetts
Sep 22, 2008 07:30 AM
- Form 3 LEWIS EARL R For: Oct 27 (10K)
Oct 29, 2008 05:31 PM
- Form 4 Giannini Daniel A For: Sep 30 (10K)
Oct 02, 2008 05:42 PM
- Form 4 NxStage Medical, Inc. For: Sep 30 Filed by: MOORE CRAIG W (10K)
Oct 02, 2008 05:37 PM
- Form 4 CHAMBON PHILIPPE For: Sep 30 (10K)
Oct 02, 2008 05:37 PM
- Form 4 REID PERPER For: Sep 30 (10K)
Oct 02, 2008 05:31 PM
- Form 4 ISALY SAMUEL D For: Aug 26 (10K)
Aug 28, 2008 06:26 PM
- Form 4 ISALY SAMUEL D For: Aug 21 (10K)
Aug 25, 2008 07:35 PM
- Form 4 NxStage Medical, Inc. For: Aug 21 Filed by: PHILDIUS PETER P (10K)
Aug 22, 2008 07:06 PM
- Form 4 NxStage Medical, Inc. For: Aug 12 Filed by: MOORE CRAIG W (10K)
Aug 13, 2008 05:46 PM
- Form 4 NxStage Medical, Inc. For: Jul 23 Filed by: ORBIMED ADVISORS LLC (10K)
Aug 12, 2008 06:14 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
NXTM
|
Compare to S&P
|
| YTD |
-85.76 %
|
-0.01 %
|
| 4 Weeks |
-46.13 %
|
-36.17 %
|
| 12 Weeks |
-40.98 %
|
-14.86 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 9.38 %
|
|
EPS Growth in Last Year: 46.30 %
|
|
Sales Growth in Last Quarter: -3.64 %
|
|
Sales Growth in Last Quarter: 162.07 %
|
|
|
